Equities

Biomerica Inc

BMRA:NAQ

Biomerica Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)0.2806
  • Today's Change-0.037 / -11.51%
  • Shares traded100.59k
  • 1 Year change-74.26%
  • Beta-1.1035
Data delayed at least 15 minutes, as of Sep 20 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Biomerica, Inc. is a biomedical technology company that develops, patents, manufactures and markets advanced diagnostic and therapeutic products. Its diagnostic test kits are utilized in the analysis of blood, urine, nasal, or fecal samples for the diagnosis of various diseases, food intolerances, and other medical conditions. Its range of medical diagnostic products is sold primarily in two markets: clinical laboratories and point-of-care settings, including physicians’ offices and over-the-counter sales. It is focused on research and development efforts and is its patented diagnostic-guided therapy (DGT) product, developed on the in Foods technology platform. Its inFoods IBS product, uses a simple blood test to identify patient-specific foods that, when eliminated, may alleviate IBS symptoms such as pain, bloating, diarrhea, cramping, and constipation. Its hp+detect, a new diagnostic test for detecting Helicobacter pylori (H. pylori) bacteria in the gastrointestinal tract.

  • Revenue in USD (TTM)5.41m
  • Net income in USD-5.98m
  • Incorporated1971
  • Employees63.00
  • Location
    Biomerica Inc17571 VON KARMAN AVENUEIRVINE 92614United StatesUSA
  • Phone+1 (949) 379-2875
  • Fax+1 (949) 553-1231
  • Websitehttps://biomerica.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Tenon Medical Inc3.37m-13.87m3.09m21.00------0.9169-39.79-39.799.451.760.42522.275.27160,571.40-174.87---495.99--60.32---411.27--1.02--0.00--323.73--17.63------
ReShape Lifesciences Inc8.05m-9.02m3.29m31.00--1.08--0.4091-1.29-1.290.47660.10330.8820.80354.79259,548.40-98.88-136.06-169.55-194.3267.4756.30-112.11-408.360.8875--0.00---22.79-0.947475.36---49.29--
Fuse Medical Inc18.40m3.63m3.40m31.001.28--0.92160.18470.0360.0360.2307-0.00310.95930.70185.75593,671.9018.910.750448.451.3564.9554.9819.720.65520.3143-1.131.12---8.67-6.72295.1134.66----
Therapeutic Solutions International Inc91.38k-2.00m3.91m3.00--2.84--42.76-0.0005-0.00050.000020.00030.02521.295.2430,460.00-63.67-162.32-153.29--65.1867.79-2,530.31-2,391.850.3883-6.940.3164---52.1395.3543.11------
Kelyniam Global Inc517.70k-420.28k3.94m0.00--7.27--7.60-0.0253-0.02530.03120.01790.41357.044.38---33.57---41.79--18.86---81.18--1.26--0.6232---26.47---19.10------
Nu-Med Plus Inc0.00-112.13k4.18m2.00---------0.0014-0.00140.00-0.00220.00----0.00-471.23-447.69---------------21.34--------3.56------
AccuStem Sciences Inc0.00-1.65m4.43m3.00---------0.1454-0.14540.00-0.25420.00----0.00-551.46--------------------------45.26------
Encision Inc6.56m-529.29k4.63m22.00--2.49--0.7056-0.045-0.0450.5560.15661.702.107.59298,337.30-13.69-3.03-19.50-4.1349.0051.25-8.06-1.891.01-8.890.1761---10.38-5.64-113.55---9.54--
Biomerica Inc5.41m-5.98m4.72m63.00--0.7162--0.872-0.3554-0.35540.32180.39180.45662.176.4985,920.63-50.43-44.68-61.13-51.7311.2314.11-110.44-63.822.43--0.00--1.420.810916.27---7.64--
Aethlon Medical, Inc.0.00-11.50m4.99m14.00--0.5727-----3.87-3.870.000.62510.00----0.00-84.49-76.25-98.84-85.78-------2,246.87----0.00---100.00---1.43------
ADM Tronics Unlimited Inc3.06m-472.80k5.07m7.00--4.97--1.66-0.007-0.0070.04530.01511.113.725.67---17.14-15.22-29.35-22.0942.8741.15-15.45-18.580.8954--0.3259---19.35-0.3572-810.74------
Predictive Oncology Inc1.75m-14.04m5.44m34.00--1.14--3.11-3.36-3.360.41580.71710.11081.454.2851,425.29-88.98-91.80-121.17-126.2960.2364.64-802.93-1,419.991.37--0.0634--18.244.7545.67--5.44--
Telesis Bio Inc16.28m-50.12m5.48m137.00------0.3365-29.66-30.689.615.610.19473.153.40118,832.10-57.15---64.21--49.47---293.54--1.72-52.960.356--0.2697---1.14------
BioSig Technologies Inc40.00k-18.08m5.53m4.00------138.37-1.97-1.970.00410.00660.0112--1.0710,000.00-489.14-269.73-4,711.71-363.1165.00---43,760.00-24,485.73---3,115.670.00---93.71---6.52---9.58--
Reflect Scientific Inc1.73m-53.09k5.57m7.00--2.8372.303.21-0.0006-0.00060.02030.0230.71970.846317.05247,638.60-2.2011.10-2.5913.2158.1962.48-3.0610.005.68--0.00---47.09-6.99-613.46------
Venus Concept Inc69.81m-49.93m6.00m304.00--1.62--0.0859-8.38-8.3811.920.51030.7511.032.25229,634.90-53.53-32.71-82.19-44.0168.3968.16-71.28-48.501.30-2.750.9133---23.2628.3114.76---35.08--
Data as of Sep 20 2024. Currency figures normalised to Biomerica Inc's reporting currency: US Dollar USD

Institutional shareholders

11.96%Per cent of shares held by top holders
HolderShares% Held
Granahan Investment Management, LLCas of 30 Jun 2024860.46k5.12%
Russell Investment Management LLCas of 30 Jun 2024226.12k1.34%
The Vanguard Group, Inc.as of 30 Jun 2024214.66k1.28%
Potomac Capital Management, Inc.as of 31 Dec 2023167.70k1.00%
BlackRock Fund Advisorsas of 30 Jun 2024149.08k0.89%
Geode Capital Management LLCas of 30 Jun 2024126.51k0.75%
HRT Financial LLCas of 30 Jun 202479.20k0.47%
Perritt Capital Management, Inc.as of 30 Jun 202470.00k0.42%
Fore Capital LLCas of 30 Jun 202459.68k0.36%
G1 Execution Services LLCas of 30 Jun 202459.21k0.35%
More ▼
Data from 31 Dec 2023 - 30 Jun 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.